Our Pipeline

The Company’s pipeline consists of partnered programs and a proprietary portfolio of drug candidates.

More than 70 therapeutic antibody programs based on the Company’s technologies are currently in development, of which 20 are in clinical trials. The list of product candidates includes exciting programs to treat rheumatoid arthritis, multiple sclerosis, cancer, muscle wasting, Alzheimer’s disease and many more.

Our Pipeline

Antibodies – Basics

What are antibodies? How do these molecules look like? What do they do?

Antibodies can accurately bind and detect almost any molecule. They are an essential component of the human immune system. Using antibodies to fight diseases is a logical extension of their natural role.

Antibodies – Basics

Our technology platforms

MorphoSys is committed to new technology and drug development to engineer the medicines of tomorrow.

MorphoSys has developed new technologies relating to the generation of recombinant antibodies, which set the standard for how antibodies will be made in the future.

Our technology platforms